Back
ProQR Therapeutics NV Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
22
PRQR
ProQR Therapeutics NV
Last Price:
$1.59
Seasonality Move:
-10.69%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PRQR is experiencing buying pressure, which is a positive indicator for future bullish movement.
ProQR Therapeutics NV Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.49 | Buy |
| 20-day SMA: | 1.5 | Buy |
| 50-day SMA: | 1.77 | Sell |
| 200-day SMA: | 2.06 | Sell |
| 8-day EMA: | 1.26 | Buy |
| 20-day EMA: | 0.76 | Buy |
| 50-day EMA: | 0.37 | Buy |
| 200-day EMA: | 0.1 | Buy |
ProQR Therapeutics NV Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.42 | Buy |
| Relative Strength Index (14 RSI): | 51.19 | Buy |
| Chaikin Money Flow: | 199940 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.44 - 1.64) | Buy |
| Bollinger Bands (100): | (1.65 - 2.51) | Sell |
ProQR Therapeutics NV Technical Analysis
| Feb 12 | Feb 13 | Feb 17 | Feb 18 | Feb 19 | Feb 20 | Feb 23 | Feb 24 | Feb 25 | Feb 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb | ||||||||||
| 12 | 13 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for ProQR Therapeutics NV Stock
Is ProQR Therapeutics NV Stock a Buy?
-
ProQR Therapeutics NV share price is 1.59 while PRQR 8-day simple moving average is 1.49, which is a Buy signal.
-
The stock price of PRQR is 1.59 while ProQR Therapeutics NV 20-day SMA is 1.50, which makes it a Buy.
-
ProQR Therapeutics NV 50-day simple moving average is 1.77 while PRQR share price is 1.59, making it a Sell technically.
-
PRQR stock price is 1.59 and ProQR Therapeutics NV 200-day simple moving average is 2.06, creating a Sell signal.
PRQR Technical Analysis vs Fundamental Analysis
Sell
22
ProQR Therapeutics NV (PRQR)
is a Sell
Is ProQR Therapeutics NV a Buy or a Sell?
-
ProQR Therapeutics NV stock is rated a SellThe current ProQR Therapeutics NV [PRQR] share price is $1.59. The Score for PRQR is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
ProQR Therapeutics NV Stock Info
Market Cap:
167.5M
Price in USD:
1.59
Share Volume:
279.9K
ProQR Therapeutics NV 52-Week Range
52-Week High:
3.10
52-Week Low:
1.07
Sell
22
ProQR Therapeutics NV (PRQR)
is a Sell
ProQR Therapeutics NV Share Price Forecast
-
What is the ProQR Therapeutics NV stock price today?The ProQR Therapeutics NV stock price is 1.59 USD today.
-
Will PRQR stock go up or go down?ProQR Therapeutics NV> share price is forecast to RISE/FALL based on technical indicators
-
Is ProQR Therapeutics NV overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, ProQR Therapeutics NV is overvalued.
Is ProQR Therapeutics NV Stock a Buy?
-
ProQR Therapeutics NV share price is 1.59 while PRQR 8-day exponential moving average is 1.26, which is a Buy signal.
-
The stock price of PRQR is 1.59 while ProQR Therapeutics NV 20-day EMA is 0.76, which makes it a Buy.
-
ProQR Therapeutics NV 50-day exponential moving average is 0.37 while PRQR share price is 1.59, making it a Buy technically.
-
PRQR stock price is 1.59 and ProQR Therapeutics NV 200-day simple moving average is 0.10, creating a Buy signal.
Fundamental Analysis of ProQR Therapeutics NV
Is ProQR Therapeutics NV a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.08 per share, and a decrease next year of $0.00 per share.
Technical Analysis of ProQR Therapeutics NV
Should I short ProQR Therapeutics NV stock?
-
PRQR Moving Average Covergence Divergence (MACD) indicator is 0.42, suggesting ProQR Therapeutics NV is a Buy
-
ProQR Therapeutics NV Relative Strength Index (RSI) is 51.19, which suggest ProQR Therapeutics NV is overbought
-
The Bollinger Bands (25) for ProQR Therapeutics NV is (1.44 - 1.64), which suggest ProQR Therapeutics NV is a Sell
-
The Bollinger Bands (100) for ProQR Therapeutics NV is (1.65 - 2.51), which suggest ProQR Therapeutics NV is a Sell
* ProQR Therapeutics NV stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.